探討延遲給付生物製劑對於第四期轉移性大腸癌病人存活之影響

Translated title of the contribution: The impact of delayed reimbursement of bevacizumab on overall survival in patients with metastatic colon cancer

林子鈺

Research output: Types of ThesisMaster's thesis

Translated title of the contributionThe impact of delayed reimbursement of bevacizumab on overall survival in patients with metastatic colon cancer
Original languageChinese (Traditional)
Supervisors/Advisors
  • Chang, Chee-Jen, Supervisor
StatePublished - 2019
Externally publishedYes

Cite this